JP2006515886A5 - - Google Patents

Download PDF

Info

Publication number
JP2006515886A5
JP2006515886A5 JP2006501021A JP2006501021A JP2006515886A5 JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5 JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006501021 A JP2006501021 A JP 2006501021A JP 2006515886 A5 JP2006515886 A5 JP 2006515886A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
alkoxy
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006501021A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006515886A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/001279 external-priority patent/WO2004064741A2/en
Publication of JP2006515886A publication Critical patent/JP2006515886A/ja
Publication of JP2006515886A5 publication Critical patent/JP2006515886A5/ja
Pending legal-status Critical Current

Links

JP2006501021A 2003-01-17 2004-01-20 化合物、組成物、および方法 Pending JP2006515886A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44087303P 2003-01-17 2003-01-17
US44391103P 2003-01-30 2003-01-30
PCT/US2004/001279 WO2004064741A2 (en) 2003-01-17 2004-01-20 Compounds, compositions, and methods

Publications (2)

Publication Number Publication Date
JP2006515886A JP2006515886A (ja) 2006-06-08
JP2006515886A5 true JP2006515886A5 (cg-RX-API-DMAC7.html) 2006-10-19

Family

ID=32776034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006501021A Pending JP2006515886A (ja) 2003-01-17 2004-01-20 化合物、組成物、および方法

Country Status (4)

Country Link
US (1) US20070149500A1 (cg-RX-API-DMAC7.html)
EP (1) EP1594849A4 (cg-RX-API-DMAC7.html)
JP (1) JP2006515886A (cg-RX-API-DMAC7.html)
WO (1) WO2004064741A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6794379B2 (en) 2001-06-06 2004-09-21 Tularik Inc. CXCR3 antagonists
US7009049B2 (en) 2002-02-15 2006-03-07 Cytokinetics, Inc. Syntheses of quinazolinones
US7166595B2 (en) 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
AU2003270015A1 (en) 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
WO2003103575A2 (en) 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
CA2489367A1 (en) 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
WO2004009036A2 (en) 2002-07-23 2004-01-29 Cytokinetics, Inc. Compounds compositions and methods
WO2004034972A2 (en) 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
ES2339862T3 (es) * 2003-06-20 2010-05-26 Novartis Vaccines And Diagnostics, Inc. Compuestos de piridino 1,2-a-pirimidin-4-ona como agentes anticancerosos.
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−4−オン化合物、組成物、および方法
EP1692112A4 (en) 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
ATE419249T1 (de) * 2004-04-06 2009-01-15 Novartis Vaccines & Diagnostic Inhibitoren von mitotischem kinesin
US20070287703A1 (en) * 2004-07-22 2007-12-13 Astrazeneca Ab Fused Pyrimidones Useful in the Treatment and the Prevention of Cancer
CN101027309B (zh) 2004-08-18 2010-10-27 阿斯利康(瑞典)有限公司 所选择的稠合嘧啶酮的对映体和在治疗和预防癌症中的用途
JP4545196B2 (ja) * 2005-01-19 2010-09-15 メルク・シャープ・エンド・ドーム・コーポレイション 有糸分裂キネシン阻害剤
EP1855685A4 (en) * 2005-01-19 2009-12-23 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
DE602006015658D1 (de) 2005-06-27 2010-09-02 Amgen Inc Entzündungshemmende arylnitrilverbindungen
EP1942888A2 (en) * 2005-11-02 2008-07-16 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
GEP20125415B (en) 2007-01-05 2012-03-12 Novartis Ag Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
CN118027024A (zh) * 2022-11-14 2024-05-14 南京同诺康医药科技有限公司 吡啶并[1,2-a]嘧啶-4-酮衍生物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609598A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
CA2465491A1 (en) * 2001-11-07 2003-05-15 Merck & Co., Inc. Mitotic kinesin inhibitors
WO2003103575A2 (en) * 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
WO2004009036A2 (en) * 2002-07-23 2004-01-29 Cytokinetics, Inc. Compounds compositions and methods
US20040024596A1 (en) * 2002-07-31 2004-02-05 Carney Laurel H. Noise reduction system
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS

Similar Documents

Publication Publication Date Title
JP2005523312A5 (cg-RX-API-DMAC7.html)
RU2004133325A (ru) Соединения, композиции на их основе и способы их использования
EP2545057B1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
CA2413426A1 (en) Methods and compositions utilizing quinazolinones
CN100491358C (zh) 嘧啶酮类化合物、组合物及方法
CN103649093B (zh) 取代的咪唑并吡啶和咪唑并哒嗪及其用途
AU679608B2 (en) Imidazodiazepines
RU2002103201A (ru) ИНГИБИТОРЫ Th2 -дифференцировки
CA2747326C (en) Combination of aurora kinase inhibitors and anti-cd20 antibodies
CA2866213A1 (en) Substituted azabicycles and use thereof
AU2003300255A1 (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
CA2792725A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
NZ515501A (en) Use of pyrazolo[4,3-d]pyrimidin-7-ones, pyrazolo[3,4-d]pyrimidin-4-ones, quinazolin-4-ones, purin-6-ones, pyrido[3,2-d]pyrimidin-4-ones and tetracyclic derivatives to treat nitrate-induced tolerance
EP1996550A2 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
ZA200210277B (en) Melanocortin receptor ligands.
KR20230010729A (ko) 단독 요법 및 병용 요법
US7705049B2 (en) Methods for treating non-melanoma cancers with PABA
JP2021518379A5 (cg-RX-API-DMAC7.html)
CN102665700A (zh) 治疗实体瘤和其它恶性肿瘤的方法和组合物
EP2036909A1 (en) Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
RU2005114491A (ru) Соединения, составы и способы их использования
JP2006515886A (ja) 化合物、組成物、および方法
JP2006502219A5 (cg-RX-API-DMAC7.html)
US20220079952A1 (en) Uses of Radiation and Benzodiazepine Derivatives in Cancer Therapies
Hafez et al. Design, synthesis and pharmacological evaluation of new nonsteroidal anti-inflammatory derived from 3-aminobenzothieno [2, 3-d] pyrimidines